NDC 69339-160-01 - Megestrol Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69339-160
- Requested NDC
- 69339-160-01
- Package NDCs from labels
- 69339-160-01, 69339-160-16, 69339-160-17, 69339-160-18, 69339-160-19
- Manufacturer
- Natco Pharma USA LLC | Strides Pharma, Inc
- Effective date
- 2026-01-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Megestrol Acetate - Natco Pharma USA LLC | Strides Pharma, Inc | Natco Pharma USA LLC | Strides Pharma, Inc | 2026-01-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69339-160-01 | Megestrol Acetate | 10 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 10 | 2 | |
| 69339-160-16 | Megestrol Acetate | 3 in 1 CASE | SUSPENSION | 3 | 2 | |
| 69339-160-16 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 | |
| 69339-160-17 | Megestrol Acetate | 4 in 1 CASE | SUSPENSION | 4 | 2 | |
| 69339-160-17 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 | |
| 69339-160-18 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 | |
| 69339-160-18 | Megestrol Acetate | 5 in 1 CASE | SUSPENSION | 5 | 2 | |
| 69339-160-19 | Megestrol Acetate | 10 in 1 CASE | SUSPENSION | 10 | 2 | |
| 69339-160-19 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69339-160-01 | ML - Milliliter | 69339-160 | 67edb6da-5e2c-4fcc-8a4a-3b098aaff6eb | 1 | 2023-09-05 |
| 69339-160-16 | ML - Milliliter | 69339-160 | 27f6e6c7-08d3-442e-b959-3a663f185453 | 1 | 2023-09-05 |
| 69339-160-17 | ML - Milliliter | 69339-160 | 31b3dcc7-2913-4c24-b3a6-640158ec6c37 | 1 | 2023-09-05 |
| 69339-160-18 | ML - Milliliter | 69339-160 | 59fcc138-63c5-45d5-b946-93f453f55056 | 1 | 2023-09-05 |
| 69339-160-19 | ML - Milliliter | 69339-160 | da7e552a-6eec-4c7f-993b-b3d609d66d99 | 1 | 2023-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Docusate Sodium | DOCUSATE SODIUM 100MG | Pharbest Pharmaceuticals, Inc. | 025e03e0-e273-47ed-87f7-98e388abe047 | 2026-03-05 | Warnings | F05Q2T2JA0 |
| Dry Eye Relief Sterile Lubricant Eye Drops | GLYCERIN | Similasan Corporation | 4c4cce1c-392e-354d-e063-6294a90a0ca3 | 2026-03-05 | Warnings | PDC6A3C0OX |
| Sore Throat | PHENOL GLYCERIN | CVS PHARMACY, INC | 9683bcfb-2f7e-48a4-aa79-500ee8df099a | 2026-03-02 | Warnings | PDC6A3C0OX |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | PDC6A3C0OX |
| Dermatool Hemorrhoidal | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Papalo Group LLC | 4bc06f41-7733-ebd0-e063-6294a90af7a8 | 2026-02-26 | Warnings | PDC6A3C0OX |
| DOCUSATE SODIUM | DOCUSATE SODIUM | PD-Rx Pharmaceuticals, Inc. | 5d300ea7-78eb-4e19-8333-1e42c73c4c54 | 2026-02-26 | Warnings | F05Q2T2JA0 |
| Tricitrates | TRICITRATES | Chartwell Governmental & Specialty RX, LLC. | c4ff0407-3930-4c48-afd4-d2cb3e1b18f4 | 2026-02-25 | Warnings, Adverse reactions | 2968PHW8QP 1Q73Q2JULR |
| Potassium Citrate and Citric Acid | POTASSIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC. | fd57a176-7faf-4053-b348-6ba5f192f05a | 2026-02-25 | Warnings, Adverse reactions | 2968PHW8QP |
| SENNA-S | DOCUSATE SODIUM AND SENNOSIDES | Advanced Rx LLC | d148be81-79b4-41f7-b8d8-a0e85b661592 | 2026-02-18 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | The Kroger Co. | e1a68bd9-d31a-46a6-8c08-7ad8197b6e0b | 2026-02-13 | Warnings | F05Q2T2JA0 |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| Stool Softener Laxative | DOCUSATE SODIUM | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | cb2698b1-6c58-417f-ae86-74fbe3814626 | 2026-02-03 | Warnings | F05Q2T2JA0 |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 2968PHW8QP |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.